DR. J. VERMYLEN
ActiveDR. J. VERMYLEN has been active since 2002 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €196k and a net result of €36k. Equity is growing by ~9.4% per year across the filed fiscal years. Its solvency ranks better than 58% of 19906 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2024
91
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability86▲+2
Solvency99▼-1
Growth52=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €17k at 30 days acceptable
Liquidity ample (current ratio 3.59 against 4.12 in 2023; short-term debt: 25.8% and cash: 29.7% of total assets), and 25.8% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 03-06-2025, 58 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
58 d early
2023
58 d early
2022
49 d early
2021
17 d early
2020
2 d early
2019
53 d early
← before the deadline
after the deadline →
Financials · fiscal year 2024, micro schema
Equity
€196k▼ 10.9%
2023 · €221k
2018: €110k
2019: €169k
2020: €185k
2021: €202k
2022: €234k
2023: €221k
2018 → 2024
Total assets
€265k▼ 3.8%
2023 · €275k
2018: €205k
2019: €239k
2020: €241k
2021: €228k
2022: €242k
2023: €275k
2018 → 2024
Net result
€36k▲ 6.5%
2023 · €34k
2018: €47k
2019: €60k
2020: €18k
2021: €32k
2022: €33k
2023: €34k
2018 → 2024
Working capital
€177k▲ 3.6%
2023 · €171k
2018: €-5k
2019: €65k
2020: €78k
2021: €115k
2022: €166k
2023: €171k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€185k-€202k▲ 8.8%€234k▲ 15.7%€221k▼ 5.6%€196k▼ 10.9%
Operating result€29k-€46k▲ 55.7%€45k▼ 1.1%€46k▲ 2.3%€49k▲ 5.5%
Net result€18k-€32k▲ 85.0%€33k▲ 0.5%€34k▲ 3.2%€36k▲ 6.5%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2022 the operating result has climbed two years in a row; 2024 is 6% above 2023 and is the highest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €265k
Fixed assets
€19k▼ 60.9%
Current assets
€245k▲ 8.7%
Equity and liabilities €265k
Equity
€196k▼ 10.9%
Debt
€68k▲ 24.6%
The debt ratio rises from 19.9% to 25.8%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€82k▲
2023 · €76k
Cash flow
€69k▲
2023 · €64k
Solvency
74.2%▼
2023 · 80.1%
Current ratio
3.59▼
2023 · 4.12
Quick ratio
3.59▼
2023 · 4.12
Debt / equity
0.35▲
2023 · 0.25
ROE
18.2%▲
2023 · 15.2%
ROA
13.5%▲
2023 · 12.2%
Interest coverage
353.86▲
2023 · 325.16
Debt
€68k▲
2023 · €55k
Debt ≤ 1 year
€68k▲
2023 · €55k
Income taxes
€14k▲
2023 · €12k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€275k€265k▼
Fixed assets21/28€50k€19k▼
Tangible fixed assets22/27€49k€19k▼
Land and buildings22€34k€10k▼
Plant, machinery and equipment23€15k€9k▼
Financial fixed assets28€200€200=
Current assets29/58€226k€245k▲
Amounts receivable within one year40/41€117k€112k▼
Other amounts receivable41€117k€112k▼
Current investments50/53€50k€50k=
Cash at bank and in hand54/58€52k€79k▲
Deferred charges and accrued income490/1€7k€4k▼
Equity and liabilities
Total equity and liabilities10/49€275k€265k▼
Equity10/15€221k€196k▼
Contributions10/11€12k€12k=
Reserves13€208k€184k▼
Distributable reserves133€208k€184k▼
Amounts payable17/49€55k€68k▲
Amounts payable within one year42/48€55k€68k▲
Trade debts44€3k€4k▲
Suppliers440/4€3k€4k▲
Taxes, remuneration and social security45€5k€5k▲
Taxes450/3€5k€5k▲
Other amounts payable47/48€47k€59k▲
Income statement
Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€30k€33k▲
Other operating charges640/8€2k€3k▲
Non-recurring operating charges66A€1k-
Gross operating margin9900€80k€84k▲
Operating profit (loss)9901€46k€49k▲
Financial income75/76B€8€893▲
Recurring financial income75€8€893▲
Financial charges65/66B€234€230▼
Recurring financial charges65€234€230▼
Profit (loss) for the period before taxes9903€46k€49k▲
Income taxes67/77€12k€14k▲
Profit (loss) for the period9904€34k€36k▲
Profit (loss) for the period to be appropriated9905€34k€36k▲
Appropriation of the result
Profit (loss) to be appropriated9906€34k€36k▲
Transfer from equity791/2€47k€60k▲
Transfer to equity691/2€34k€36k▲
To other reserves6921€34k€36k▲
Profit to be distributed694/7€47k€60k▲
Return on contributions (dividend)694€47k€60k▲
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
03-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
03-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
12-06
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Liquidity quadruplescurrent ratio 20.61
Current ratio from 5.42 to 20.61; short-term debt falls from €26k to €8k.
14-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial
Liquidity doublescurrent ratio 5.42
Current ratio from 2.41 to 5.42; short-term debt falls from €56k to €26k.
31-12
Financial
Equity above €200kEq €202k ▲8.8%
4 profitable years in a row build equity to €202k.
29-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial
Weakest financial yearnet €18k ▼70.7%
Net result drops to €18k, the lowest in the series; recovery starts the following year.
08-06
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
31-12
Financial
Highest result since 2018net €60k ▲28.2%
Operating result €106k, net result €60k, both a record.
31-12
Financial
Liquidity doublescurrent ratio 2.12
Current ratio from 0.93 to 2.12; short-term debt falls from €62k to €57k.
31-12
Financial
Equity above €150kEq €169k ▲53.9%
2 profitable years in a row build equity to €169k.
08-07
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
20-06
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
31-08
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema · 31 days late
2016
24-08
NBB filing
Annual accounts filed
fiscal year 2015 · abbreviated schema · 24 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Leuven · 1 establishment unit since 2002
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Geldenaaksevest 783000 LeuvenGround area
154 m²
Building footprint
91 m²
Parcel 24502C0296/00X010, Flanders. Linked by address, not a title deed.
1 establishment unit
Geldenaaksevest 78, 3000 Leuven
since 20022.228.102.569
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24502C0296/00X010 | Flanders | 154 m² | 1 · 91 m² | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Dr. Van den Broeck Thomas
BE 0803.648.661
Boechout · Eq €197k
Dr. Jose Manuel Archuleta Arteaga
BE 0786.953.872
Antwerpen · Eq €196k
PROF. DR. B. SCHMELZER
BE 0543.435.669
Wommelgem · Eq €196k
PNEUMOMEDIC
BE 0457.488.028
Andenne · Eq €197k
RUBO 15
BE 0836.149.007
Sint-Genesius-Rode · Eq €196k
Of 16,627 companies in sector 86220 we hold annual accounts for 7,973. 6,732 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded01-02-2002
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 23 filingsAddress and cadastre registers
Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.